ArticleCardiac failure review2025

Cardiovascular Benefits of Spironolactone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from a Win Ratio Analysis of the TOPCAT Trial.

Dung Viet Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.